Skip to Content

'
Sriram Yennu, MD, MS

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Palliative Care and Rehabilitation Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd
Unit Number: 1414
Houston, TX 77030
Room Number: FCT5.6000
Phone: 713-792-6085
Fax: 713-792-6092

Education & Training

Degree-Granting Education

2011 The University of Texas Health Science Center, Graduate School of Biomedical Sciences, Houston, TX, MS, Patient Oriented Biomedical Research
1995 Osmania Medical College, University of Health Sciences, Hyderabad, India, MBBS, M.B.B.S. (Bachelor of Medicine and Bachelor of Surgery)

Postgraduate Training

2003-2004 Clinical Fellowship, Symptom Control & Palliative Care, The University of Texas MD Anderson Cancer Center, Houston, TX, Eduardo Bruera, M.D.
2002-2003 Clinical Fellowship, Geriatric Medicine, University Hospital of New York Medical College, Our Lady of Mercy Medical Center, Bronx, NY
1999-2002 Clinical Residency, Internal Medicine, Mount Sinai Services (Affiliated to Mount Sinai School of Medicine), Queens Hospital Center, Queens, NY
1998 Voluntary Clinical Externship, Internal Medicine, Conemaugh Memorial Hospital and Queens Hospital Center, Johnstown, PA
1997-1998 Voluntary Clinical Externship, Ambulatory Care (ER), VA Medical Center, Dallas, TX
1994-1995 Clinical Internship, Osmania General Hospital and Affiliates, Hyderabad, India

Board Certifications

1/2010 American Board of Internal Medicine, Added Qualification in Hospice and Palliative Medicine
1/2005 American Board of Hospice and Palliative Medicine
11/2003 American Board of Internal Medicine, Added Qualification in Geriatrics Medicine
1/2002 American Board of Internal Medicine

Experience/Service

Administrative Appointments/Responsibilities

Temporary Director, Department of Palliative Care and Rehabilitation Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2004-8/2004

Other Appointments/Responsibilities

Senior House Officer, Osmania General Hospital and Affiliates, Hyderabad, India, 1995-1997

Consultantships

Consultant, Hospital Israelita Albert Einstein, Sao Paulo, Brazil, 2012-present
Consultant, The Leon-Berard Multidisciplinary Center, Lyon, France, 2011-present

Institutional Committee Activities

Advisory Board Member, Scientific Publications Committee, 2012-present
Member, Cancer Center Support Grant (CCSG) Programs, Behavioral & Health Disparities Research, 2012-present
Alternate Member, Credentials Committee of the Medical Staff (CCMS), 2012
Member, Global Academic Programs - Africa Steering Committee, 2011-present
Member, Clinical Research Committee (CRC), 2010-present
Chair, Annual Palliative Care Research Curriculum Course for Fellows and Faculty, 2009-present
Chair, Research Committee, Department of Palliative Care and Rehabilitation Medicine, Division of Cancer Medicine, 2007-present
Associate Member, Institutional Review Board, 2006-2011
Conference Chair, Intensive Physician Board Review Course in Hospice and Palliative Medicine, 2005-present
Chair, Annual Interdisciplinary Conference on Supportive Care, Hospice and Palliative Medicine, 2005-present
Ad Hoc Reviewer, Community Clinical Oncology Program (CCOP), 2005

Honors and Awards

2013 AAHPM Award for Young Investigators - Dexamethasone for symptom distress in advanced cancer: A double-blind, randomized, placebo-controlled trial (TH307-C), American Academy of Hospice and Palliative Medicine (AAHPM)
2011 Research Scholar Award, American Cancer Society
2009 Research Scholar Award, American Academy of Hospice and Palliative Medicine, American College of Palliative Care

Professional Memberships

American Academy of Hospice and Palliative Medicine (AAHPM), Glenview, IL
Member, 2005-present
American Medical Association (AMA)
Member, 2005-present
American Society of Clinical Oncology (ASCO), Alexandria, VA
Member, 2005-present
European Association of Palliative Care (EAPC), Milano, Italy
Member, 2006-2009
International Society of Geriatric Oncology
Member, 2005-2009
Multinational Association for Supportive Care in Cancer (MASCC), Denmark
Member, 2010-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Kang JH, Kwon JH, Hui D, Yennurajalingam S, Bruera E. Changes in symptom intensities among cancer patients receiving outpatient palliative care. J Pain and Symptom Manage. In Press.
2. Yennurajalingam S, Parsons HA, Duarte ER, Palama A, Bunge S, Palmer LJ, Delgado-Guay MO, Allo J, Bruera E. Decisional control preferences of advanced cancer hispanic patients from the united states and latin america. J Pain Symptom Manage. In Press.
3. Yennurajalingam S, Noguera A, Parsons HA, Torres-Vigil I, Duarte ER, Palma A, Bunge S, Plamer JL, Delgado-Guay MO, Bruera E. Family caregiver preferences of the patients decisional control among Hispanics in the United States and Latin America. Palliat Medicine. In Press.
4. Bruera E, Yennurajalingam S, Palmer JL, Perez-Cruz PE, Frisbee-Hume S, Allo JA, Williams JL, Cohen MZ. Methylphenidate and/or a Nursing Telephone Intervention for Fatigue in Patients with Advanced Cancer: A Randomized Placebo-Controlled Phase II Trial. J Clin Oncol. In Press.
5. Rhondali W, Yennurajalingam S, Chisholm G, Ferrer J, Kim SH, Kang JH, Filbet M, Bruera E. Predictors of response to palliative care intervention for chronic nausea in advanced cancer outpatients. Support Care Cancer. In Press.
6. Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy AS, Hui D, Dalal S, Massie L, Vadhan-Raj S, Reddy SK, Reuben JM, Bruera E. Reduction of cancer-related fatigue with dexamethasone: A double-blind, randomized, placebo-controlled trial. J Clin Oncol. In Press.
7. Berger AM, Yennurajalingam S, Million RM. Update on interventions focused on symptom clusters: What has been tried and what have we learned? Current Opinions in Supportive Care. In Press.
8. Dev R, Coulson L, Del Fabbro E, Palla S, Yennurajalingam S, Rhondali W, Bruera E. A prospective study of family conferences: effects of patient presence on emotional expression and end-of-life discussions. J Pain and Symptom Manage. e-Pub 3/2013. PMID: 23507128.
9. Yennurajalingam S, Kwon JH, Urbauer DL, Hui D, Reyes-Gibby CC, Bruera E. Consistency of symptom clusters among advanced cancer patients seen at an outpatient supportive care clinic in a tertiary cancer center. Palliat Support Care:1-8, 2/2013. PMID: 23388652.
10. Kwon JH, Hui D, Chisholm G, Ha C, Yennurajalingam S, Kang JH, Bruera E. Clinical characteristics of cancer patients referred early to supportive and palliative care. J Palliat Med, 1/2013.
11. Shah AB, Udeoji DU, Baraghoush A, Bharadwaj P, Yennurajalingam S, Schwarz ER. An evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med 16(1):87-90, 2013.
12. Hui D, Glitza I, Chisholm G, Yennurajalingam S, Bruera E. Attrition rates, reasons and predictive factors in supportive and palliative oncology clinical trials. Cancer, 11/2012.
13. Pimental L, Yennurajalingam S, Brown ED, Castro DK. Challenges of managing advanced cancer patients through phone triaging at an outpatient supportive care clinic: A case series of palliative care patients. Palliative Care: Research and Treatment 6:9-14, 11/2012.
14. Yennurajalingam S, Reddy A, Pulivarthi K, Palla SL, Wang X, Kwon JH, Frisbee-Hume S, Bruera E. Frequency, outcome, and predictors of successful opioid rotation in cancer patients referred to an outpatient supportive care center. Oncologist, 11/2012.
15. Reyes-Gibby C, Wang J, Wu X, Yennurajalingam S, Shete S. Genetic variations in interleukin 8 and 10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage, 11/2012.
16. Yennurajalingam S, Willey JS, Palmer JL, Allo J, Fabbro ED, Cohen EN, Tin S, Reuben JM, Bruera E. The role of thalidomide and placebo for the treatment of cancer-related-anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. J Palliat Med 15(10):1059-64, 10/2012. e-Pub 8/2012. PMCID: PMC3438834.
17. Yennurajalingam S, Kang JH, Hui D, Kang DH, Kim SH, Bruera E. Clinical response to an outpatient palliative care consultation in patients with advanced cancer and cancer pain. J Pain Symptom Manage 44(3):340-50, 9/2012. e-Pub 6/2012. PMID: 22699092.
18. Yennurajalingam S, Urbauer D, Bruera E. Factors associated with the severity and improvement of fatigue in patients with advanced cancer presenting to an outpatient palliative care clinic. BMC Palliat Care 11(1). e-Pub 9/2012. PMID: 22985058.
19. Reddy A, Yennurajalingam S, Bruera E. Whatever my mother wants: Barriers to adequate pain management. J Palliat Med. e-Pub 9/2012. PMID: 22946542.
20. Yennurajalingam S, Kang JH, Cheng HY, Chisholm GB, Kwon JH, Palla SL, Bruera E. Characteristics of Advanced Cancer Patients With Cancer-Related Fatigue Enrolled in Clinical Trials and Patients Referred to Outpatient Palliative Care Clinics. J Pain Symptom Manage. e-Pub 8/2012. PMID: 22917716.
21. Reyes-Gibby CC, Anderson KO, Shete S, Bruera E, Yennurajalingam S. Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-hispanic whites, hispanics, and non-hispanic blacks. Cancer 118(3):856-63, 2/2012. e-Pub 7/2011. PMCID: PMC3193905.
22. Yennurajalingam S, Atkinson B, Masterson J, Hui D, Urbauer D, Tu SM, Bruera E. The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. J Palliat Med 15(1):20-4, 1/2012. e-Pub 12/2011. PMID: 22141432.
23. Yennurajalingam S, Delgado-Guay M, Parsons H, Palmer JL, Bruera E. Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J Pain Symptom Manage 41(5):819-27, 5/2011. e-Pub 2/2011. PMID: 21306864.
24. Dev R, Hui D, Dalal S, Nooruddin ZI, Yennurajalingam S, Del Fabbro E, Bruera E. Association between serum cortisol and testosterone levels, opioid therapy, and symptom distress in patients with advanced cancer. J Pain Symptom Manage 41(4):788-95, 4/2011. e-Pub 1/2011. PMID: 21276699.
25. Yennurajalingam S, Palmer JL, Chacko R, Bruera E. Factors associated with response to methylphenidate in advanced cancer patients. Oncologist 16(2):246-53, 2011. e-Pub 1/2011. PMCID: PMC3228096.
26. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller TP, Palla SL, Rhondali W, Kang JH, Kim SH, Del Fabbro E, Zhukovsky DS, Reddy S, Elsayem A, Dalal S, Dev R, Walker P, Yennurajalingam S, Reddy A, Bruera E. The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist 16(11):1642-8, 2011. e-Pub 10/2011. PMCID: PMC3233300.
27. Hui D, Parsons H, Nguyen L, Palla SL, Yennurajalingam S, Kurzrock R, Bruera E. Timing of palliative care referral and symptom burden in phase I cancer patients: a retrospective cohort study. Cancer 116(18):4402-9, 9/2010. PMCID: PMC2936661.
28. Yennurajalingam S, Urbauer DL, Casper KL, Reyes-Gibby CC, Chacko R, Poulter V, Bruera E. Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage 41(1). e-Pub 8/2010. PMID: 20739141.
29. Yennurajalingam S, Dev R, Walker PW, Reddy SK, Bruera E. Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: A report of three cases. J Pain Symptom Manage 39(5):930-935, 5/2010. PMID: 20471553.
30. Hui D, Bush SH, Gallo LE, Palmer JL, Yennurajalingam S, Bruera E. Neuroleptic dose in the management of delirium in patients with advanced cancer. J Pain Symptom Manage 39(2):186-196, 2/2010. PMID: 20152585.
31. Hui D, Elsayem A, Palla S, De La Cruz M, Li Z, Yennurajalingam S, Bruera E. Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center. J Palliat Med 13(1):49-57, 1/2010. PMCID: PMC2883821.
32. Reyes-Gibby CC, Spitz MR, Yennurajalingam S, Swartz M, Gu J, Wu X, Bruera E, Shete S. Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev 18(10):2636-42, 10/2009. e-Pub 9/2009. PMCID: PMC2759856.
33. Reyes-Gibby CC, Shete S, Yennurajalingam S, Frazier M, Bruera E, Kurzrock R, Crane CH, Abbruzzese J, Evans D, Spitz MR. Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: Assessing the influence of cytokine genes. J Pain Symptom Manage 38(6):894-902, 2009. PMCID: PMC2795073.
34. Yennurajalingam S, Dev R, Lockey M, Pace E, Zhang T, Palmer JL, Bruera E. Characteristics of family conferences in a pallaitive care unit at a comprehensive cancer center. J Palliat Med 11(9):1208-11, 11/2008. PMID: 19021483.
35. Yennurajalingam S, Palmer JL, Zhang T, Poulter V, Bruera E. Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer 16(10):1125-30, 10/2008. e-Pub 5/2008. PMID: 18504622.
36. Delgado-Guay MO, Yennurajalingam S, Bruera E. Delirium with severe symptom expression related to hypercalcemia in a patient with advanced cancer: An interdisciplinary approach to treatment. J Pain Symptom Manage 36(4):442-9, 10/2008. e-Pub 4/2008. PMID: 18440772.
37. El Osta B, Elsayem A, Yennurajalingam S, Bruera E. Intractable pain:Intoxication or undermedication? J Palliat Med 10(3):811-4, 6/2007. PMID: 17592996.
38. Yennurajalingam S, Zhang T, Bruera E. The impact of the palliative care mobile team on symptom assessment and medication profiles in patients admitted to a comprehensive cancer center. Support Care Cancer 15(5):471-5, 5/2007. e-Pub 11/2006. PMID: 17093911.
39. Garyali A, Palmer JL, Yennurajalingam S, Zhang T, Pace EA, Bruera E. Errors in symptom intensity self-assessment by patients receiving outpatient palliative care. J Palliat Med 9(5):1059-65, 10/2006. PMID: 17040143.
40. Paiva CE, Ribeiro Paiva, BS, b|Yennurajalingam S, Hui D. Association between individual prayer activity and inflammation, quality of life, and survival of advanced cancer patients. J Palliative Medicine. Submitted.
41. Hui D, dos Santos R, Swati B, Silva TB, Kilgore K, Crovador CS, Chisholm G, Yu X, Swartz MD, Perez-Cruz PE, de Almeida Leite R, Salete de Angelis Nascimento M, Reddy S, Seriaco F, Yennurajalingam S, Paiva CE, Dev R, Hall S, Fajardo J, Bruera E. Clinical Signs of Impending Death in Cancer Patients. Lancet Oncology. Submitted.
42. Yennurajalingam S, Chisholm G, Palla SL, Holmes H, Reuben JM, Bruera E. Self-reported sleep disturbance in patients with advanced cancer: frequency, intensity, and factors associated with response to outpatient supportive care consultation: preliminary report. European Journal of Cancer Care. Submitted.
43. Reyes-Gibby C, Swartz M, Yu X, Spitz M, Anderson K, Yennurajalingam S, Wu X, Shete S. Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes. Cancer. Submitted.

Invited Articles

1. Bruera E, Yennurajalingam S. Palliative care in advanced cancer patients: how and when. Oncologist 17(2):267-73, 2012. e-Pub 1/2012. PMCID: PMC3286176.
2. Bruera E, Yennurajalingam S. Overview of fatigue, weakness and asthenia in palliative care. UpToDate 0.5, 2010.
3. Yennurajalingam S, Bruera E. Palliative management of fatigue at the close of life: It feels like my body is just worn out. JAMA 297(3):295-304, 1/2007. PMID: 17227981.
4. Yennurajalingam S, Braiteh F, Bruera E. Pain and terminal delirium research in the elderly. Clin Geriatr Med 21(1):93-119, 2/2005. PMID: 15639040.
5. Yennurajalingam S, Peuckmann V, Bruera E. Recent developments in cancer pain assessment and management. Support Cancer Ther 1(2):97-110, 1/2004. PMID: 18628186.

Editorials

1. Bruera E, Yennurajalingam S. Challenge of managing cancer related fatigue. J Clin Oncol 28(23):3671-2, 8/2010. e-Pub 7/2010. PMID: 20625135.

Abstracts

1. Reyes-Gibby CC, Bruera E, Yennurajalingam S. Symptom burden as a predictor of early referral to palliative care specialists: non-hispanic whites, hispanics, and non-hispanic blacks in a tertiary treatment center in the US. Latino Americano Palliative Congress. In Press.
2. Yennurajalingam S, Kang JH, Cheng HY, Chisholm GB, Kwon JH, Palla SL, Bruera E. Characteristics of advanced cancer patients with cancer-related fatigue enrolled in clinical trials and patients referred to outpatient palliative care clinics. J Pain Symptom Manage 43(2):471-472, 8/2012.
3. Arthur J, Nguyen L,Hui D, Bruera E, Yennurajalingam S. Characteristics of cancer pain in an outpatient palliative care center according to the ECS-CP. J Pain Symptom Manage 43(2):466, 2/2012.
4. Dev R, Coulson LC, Pulivarthi K, Del Fabbro E, Palla SL, Yennurajalingam S, Bruera E. A prospective study of family conferences (FCs) in a palliative care unit (PCU) at a comprehensive cancer center. J Clin Oncol 30(Suppl; abstr 9127), 2012.
5. Dev R, Coulson L, Pulivarthi K, Del Fabbro E, Palla S, Yennurajalingam S, Bruera E. A prospective study of family conferences (FCs) in a palliative care unit (PCU) at a comprehensive cancer center. Support Care Cancer 20(Supplement 1):238-239, 2012.
6. Kwon JH, Hui D, Ha CA, Chisholm GB, Yennurajalingam S, Kang JH, Bruera E. Clinical needs of patients referred early to supportive and palliative care. J Clin Oncol 30(suppl; abstr 9065), 2012.
7. Hui D, dos Santos R, Kilgore KL, Silva TB, Chisholm GB, Perez-Cruz PE, Crovador CS, de Almeida Leite R, Del Fabbro E, de Angelis Nascimento MA, Zhukovsky DS, de Lourdes Gonõaves de Freitas Seriaco F, Reddy SK, Machado Frascari L, Yennurajalingam S, Paiva CE, Dev R, Hal S, Fajardo J, Bruera E. Clinical signs of dying in cancer patients: A prospective longitudinal observational study. J Clin Oncol 30(suppl; abstr e19528), 2012.
8. Parsons HA, Yennurajalingam S, Duarte ER, Palma A, Bunge S, Palmer JL, Delgado-Guay MO, Bruera E. Decision-making preferences of advanced cancer hispanic patients from the united states and latin america. J Clin Oncol 30((suppl; abstr 9063)), 2012.
9. Yennurajalingam S. Decision-making preferences of advanced cancer hispanic patients from the united states and latin america. Support Care Cancer 20 (Suppl 1)(S1110), 2012.
10. Yennurajalingam S. Dexamethasone (DM) for cancer related fatigue: A double- blinded, randomized, placebo-controlled trial. J Clin Oncol(30 (suppl; abstr 9002)), 2012.
11. Yennurajalingam S. Dexamethasone and symptom distress: Results of a placebo controlled double blind randomized controlled trial in patients with advanced cancer. Support Care Cancer(20 (Suppl 1)):S981, 2012.
12. Reddy A, Yennurajalingam S, Pulivarthi K, Palla S, Wang X, Kwon JH, Frisbee-Hume S, Bruera E. Frequency, indications, outcomes and factors associated with successful opioid rotation (OR) in cancer patients presenting to an outpatient supportive care center (SCC). Support Care Cancer 20(Suppl 1):S785, 2012.
13. Bruera E, Yennurajalingam S, Perez-Cruz PE, Hui D, Frisbee-Hume S, Allo J, Palmer JL. Methylphenidate (MP) and nursing telephone intervention (NTI) for cancer related fatigue (CRF) in advanced cancer patients: A double blind randomized phase II trial. J Clin Oncol 30(suppl; abstr 9023), 2012.
14. Bruera E, Yennurajalingam S, Perez-Cruz PE, Frisbee-Hume S, Hui D, Palmer JL. Methylphenidate (MP) and nursing telephone intervention (NTI) for cancer related fatigue (CRF) in advanced cancer patients: A double blind randomized phase II trial. Support Care Cancer 20(Suppl 1):S1091, 2012.
15. Holmes HM, Des Bordes JKA, Luo R, Kebriaei P, Yennurajalingam S, Mohile S. Abnormalities on comprehensive geriatric assessment in older persons prior to allogeneic stem cell transplatation. J Geriatr Oncol 2(Suppl 1)(S44), 2011.
16. Paiva CE, Yennurajalingam S. Association of feeling of well-being and other cancer related symptoms in ambulatory advanced cancer patients according to primary tumor sites. Support Care Cancer 19 (Suppl 2)(S266), 2011.
17. Yennurajalingam S, Rueben JM, Palmer JL, Cohen EN, Tin S, Wu Q, Bruera B. Cancer-related-fatigue (CRF) is associated with IL-6, IL-6R and IL-17, while IL-8 & IL-6 are associated with no improvement of CRF after treatment. Support Care Cancer(19 (Suppl 2)):S494, 2011.
18. Kuriya M, Wei Wei (Auston), Palla S, Bruera E, Yennurajalingam S. Frequency and factors associated with falls in patients with advanced cancer consulted to outpatient supportive care clinic. Support Care Cancer 19(Suppl 2):S67S370, 2011.
19. Kang JH, Yennurajalingam S, Chisholm G, Kim SH, Rhondali W, Hui D, Bruera E. Frequency and predictors of response to outpatient palliative care in patients with moderate to severe cancer pain. J Clin Oncol 29(suppl; abstr e19698), 2011.
20. Hui D, Kilgore KL, Nguyen LMT, Hall S, Fajardo J, Cox-Miller T, Urbauer D, Fellman B, Rhondali W, Kang JH, Kim SH, Del Fabbro E, Zhuskovsky DS, Reddy SK, Elsayem AF, Dalal S, Walker P, Dev R, Yennurajalingam S, Bruera E. Predictors of in-hospital mortality in advanced cancer patients admitted to an acute palliative care unit (APCU): A prospective study. Support Care Cancer 19(Suppl 2):S461, 2011.
21. Yennurajalingam S, Kang JH, Chicholm G, Hui D, Bruera E. Response rate to outpatient palliative care in patients(pts) with cancer pain. Support Care Cancer 19(Suppl 2):SX, 2011.
22. Yennurajalingam S, Chisholm G, Palla SL, Bruera E. Sleep disturbance in advanced cancer patients: Frequency and factors associated with response to specialist based outpatient supportive care. J Clin Oncol 29(suppl; abstr 9069), 2011.
23. Dev R, Del Fabbro E, Hui D, Palla SL, Dalal S, Yennurajalingam S, Bruera E. Vitamin D deficiency and endocrine abnormalities in advanced cancer patients. Support Care Cancer 19(Suppl 2):S187, 2011.
24. Yennurajalingam S, Urbauer D, Busby K, Chacko R, Poulter V, Bruera E. Improvement of symptom distress in patients with advanced cancer. American Association of Hospice and Palliative Medicine, Annual Assembly, 3/2010.
25. Yennurajalingam S, Palmer JL, Zhijun L, Bruera E. Factors associated with response to methylphenidate in advanced cancer patients with cancer-related fatigue. J Clin Oncol 28(15s (suppl; abstr 9005)), 2010.
26. Yennurajalingam S, Urbauer DL, Hui D, Bruera E. Factors associated with the severity of cancer related fatigue in patients with advanced cancer presenting to supportive care clinic. Current Oncology 17(5), 2010.
27. Yennurajalingam S, Palmer JL, Bruera E. The effect of dexamethasone on symptom burden in patients with advanced cancer. J Clin Oncol 28(15s (suppl; abstr TPS318)), 2010.
28. Parsons HA, Hui D, Nguyen L, Palla SL, Lui J, Yennurajalingam S, Kurzrock R, Bruera E. Timing of palliative care referral and symptom burden in phase I cancer patients. A retrospective cohort study. J Clin Oncol 28(15s (suppl; abstr 9062)), 2010.
29. Masterson J, Atkinson B, Hui D, Tu S, Bruera E, Yennurajalingam S. Characteristics of fatigue in patients with advanced prostate cancer. Support Care Cancer, 6/2009.
30. Yennurajalingam S, Urbaurer D, Amin Y, Evans A, Orihuela C, Bruera E. Factors associated with fatigue and predictors of improvement of fatigue in patients with advanced cancer. MASCC/ISOO 2009 International Symposium Supportive Care in Cancer, 6/2009.
31. Yennurajalingam S, Urbauer DL, Chacko R, Hui D, Amin YA, Evans AC, Orihuela C, Casper KL, Poulter V, Coldman B, Bruera E. Impact of an outpatient interdisciplinary (IDT) team consultation on symptom clusters in advanced cancer patients seen at a supportive care outpatient clinic (OPC) in a tertiary cancer center. J Clin Oncol:suppl; abstr e20542, 2009.
32. Yennurajalingam S. Well-being, drowsiness, decreased appetite, and anxiety are predictors of fatigue in patients with advanced cancer. Palliat Med(22):399-565, 6/2008.
33. Yennurajalingam S, Palmer JL, Zhang T, Poulter V, Bruera E. Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Suppotive Care in Cancer 16(10):1125-1130, 2008.
34. Yennurajalingam S. Characteristics of fatigue symptom clusters in patients with advanced cancer. 17th International Congress on Palliative Care, 2008.
35. Yennurajalingam S, et al. Fatigue symptom clusters myth or reality?. J Clin Oncol 26(May 20 suppl):abstr 20564, 2008.
36. Yennujalingam S, et al. Impact of interdisciplinary team (IDT) on fatigue and symptom composite at outpatient palliative care center in a tertiary cancer center. European Association of Palliative Care Meeting, 2008.
37. Yennurajalingam S. Family conference: a safe and well-accepted tool for communication in palliative care of advanced cancer patients in a comprehensive cancer center [retrospective study of 128 patients]. European Association of Palliative Care Meeting, 6/2006.
38. Yennurajalingam S. Family conferences - Their role in the palliative care setting. 8th Annual Interdisciplinary Approach to Symptom Control and Palliative Care, 10/2005.
39. Yennurajalingam S, Zhang T, Bruera E. The impact of the palliative care mobile team on symptom assessment and medication profiles in patients admitted to a comprehensive cancer center. Support Care Cancer 15(5):471-475, 2005.
40. Yennurajalingam S. Dexamethasone for symptom distress in advanced cancer : A double-blind, randomized, placebo-controlled trial. American Academy of Hospice and Palliative Medicine. Submitted.
41. Yennurajalingam S, Palmer JL, Li Z, Bruera E. Factors associated with response to methylphenidate in advanced cancer patients with cancer related fatigue. American Society of Clinical Oncology. Submitted.
42. Holmes H, des Bordes J, Kebriaei P, Luo R, Yennu S, Morris GS, Giralt S, Mohile S. Vulnerable elders survey and comprehensive geriatric assessment results in stem cell transplant patients. Submitted.

Book Chapters

1. Didwaniya N, Yennurajalingam S. Management of cancer related fatigue. In: Textbook of Palliative Medicine, Second. Ed(s) Bruera E, Higginson IJ, Von Gunten CF, Morita T. Hodder Education: London, England. In Press.
2. Pedraza SL, Balachandran D, Yennurajalingam S. Sleeping disorders. In: Textbook of Palliative Medicine, Second. Ed(s) Bruera E, Higginson IJ,Von Gunten CF, Morita T. Hodder Education: London, England. In Press.
3. Yennurajalingam S, Bruera E. Definitions and key elements in palliative care. In: Oxford American Handbook of Hospice and Palliative Medicine. 1, 1. Ed(s) Yennurajalingam S, Bruera E. Oxford University Press: New York, NY, 1-7, 2011. ISBN: 978-0-19-538015-6.
4. Yennurajalingam S. Fatigue. In: Oxford American Handbook of Hospice and Palliative Medicine. 1, 1. Ed(s) Yennurajalingam S, Bruera E. Oxford University Press: New York NY, 73-85, 2011.
5. Leech A, Yennurajalingam S. Palliative care in end-stage chronic obstructive pulmonary disease. In: Oxford American Handbook of Hospice and Palliative Medicine. 1, 1. Ed(s) Yennurajalingam S, Bruera E. Oxford University Press: New York NY, 415-424, 2011.
6. Yennurajalingam S, Bruera E. Research in terminally ill patients. In: Oxford American Handbook of Hospice and Palliative Medicine. 1, 1. Ed(s) Yennurajalingam S, Bruera E. Oxford University Press: New York NY, 439-447, 2011.
7. Delgado-Guay MO, Yennurajalingam S. Sleep disturbance. In: Oxford American Handbook of Hospice and Palliative Medicine. 1, 1. Ed(s) Yennurajalingam S, Bruera E. Oxford University Press: New York NY, 115-126, 2011.
8. Delgado-Guay MO, Yennurajalingam S. Symptom assessment. In: Oxford American Handbook of Hospice and Palliative Medicine. 1, 1. Ed(s) Yennurajalingam S, Bruera E. Oxford University Press: New York NY, 9-21, 2011.
9. Yennrajalingam S, Bruera E. Palliative management of fatigue at the close of life. In: JAMA Care at the Close of Life. McGraw-Hill: Burr Ridge, IL, 2010.
10. Yennurajalingam S, Bruera E. Fatigue and asthenia. In: Oxford Textbook of Palliative Care, 4th. Oxford University Press: United Kingdom, 916-927, 2009.

Books (edited and written)

1. Hui D. Approach to internal medicine, A resource book for clinical practice. In: Palliative care. Series Ed(s) Yennurajalingam S, Bruera E. Springer: New York, 2011.
2. Yennurajalingam S, Bruera E. Ed(s) Yennurajalingam S, Bruera E. Oxford handbook on hospice & palliative medicine. Series Ed(s) Yennurajalingam S, Bruera E. 1, 1. Oxford University Press: New York, NY, 2011. ISBN: 978-0-19-538015-6.
3. Yennurajalingam S. The association between cancer-related-fatigue, response to fatigue treatment, and cytokines and their receptors, in patients with advanced cancer. In: UT GSBS Dissertations and Theses. DigitalCommons@The Texas Medical Center: Houston, 2011.

Letters to the Editor

1. Bruera E, Yennurajalingam S. In reply. Oncologist 17(6):e12, 2012. PMID: 22605344.
2. Yennurajalingam S, Palla S, Bruera E. The impact of palliative care on symptoms, quality of life, and survival. Palliative Care: Research and Treatment 4:1-2, 2010.

Manuals, Teaching Aids, Other Teaching Publications

1. Yennurajalingam S. Intensive board review course book in hospice and palliative medicine. The University of Texas MD Anderson Cancer Center: Houston, 2012.
2. Yennurajalingam S. Intensive board review course book in hospice and palliative medicine. The University of Texas MD Anderson Cancer Center: Houston, 2011.
3. Yennurajalingam S. Intensive board review course book in hospice and palliative medicine. The University of Texas MD Anderson Cancer Center: Houston, 2010.
4. Yennurajalingam S. Intensive board review course book in hospice and palliative medicine. The University of Texas MD Anderson Cancer Center: Houston, 2009.
5. Yennurajalingam S. Intensive board review course book in hospice and palliative medicine. The University of Texas MD Anderson Cancer Center: Houston, 2008.
6. Yennurajalingam S. Intensive board review course book in hospice and palliative medicine. The University of Texas MD Anderson Cancer Center: Houston, 2007.
7. Yennurajalingam S. Intensive board review course book in hospice and palliative medicine. The University of Texas MD Anderson Cancer Center: Houston, 2006.
8. Yennurajalingam S. Intensive board review course book in hospice and palliative medicine. The University of Texas MD Anderson Cancer Center: Houston, 2005.

Grant & Contract Support

Title: Exercise +/- Dexamethasone for CRF in patients with advanced cancer
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 9/1/2013 - 8/31/2018
 
Title: Cranial stimulation: Symptom management and biologic responses in palliative care
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Kang DH
Duration: 9/1/2013 - 8/31/2015
 
Title: Armodafinil for opioid induced fatigue and sedation
Funding Source: TEVA
Role: Principal Investigator
Duration: 3/1/2013 - 4/30/2018
 
Title: Novel Symptom Response Criteria and Predictors in Advanced Cancer Patient
Funding Source: Sisters Institution Network Fund
Role: Co-Investigator
Principal Investigator: Hui D
Duration: 6/1/2012 - 6/1/2013
 
Title: Effects of Palliative Care on Quality of Life, Outcomes and Costs in Patients with Heart Failure
Funding Source: NIH/NHLBI
Role: Principal Investigator
Duration: 4/2012 - 3/2017
 
Title: Integrating palliative with standard care to improve survival, QOL & cost of care
Funding Source: NIH/NHLBI
Role: Principal Investigator
Duration: 1/2012 - 12/2015
 
Title: The Effects of Ginseng on Cancer-Related Fatigue
Funding Source: Indena S.p.A.
Role: Principal Investigator
Duration: 10/14/2011 - 6/30/2015
 
Title: Multimodal Study for Cancer Related Fatigue, Research Scholar Grant for Independent Investigators
Funding Source: American Cancer Society (ACS)
Role: Principal Investigator
Duration: 7/1/2011 - 6/30/2014
 
Title: Efficacy of psychotherapy and/or methylphenidate and exercise to treat cancer fatigue
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 4/2011 - 3/2015
 
Title: A pilot open label study to investigate the role of Lenalidomide in improving cancer related sleep in CLL patients over 65 years of age experiencing clinically significant fatigue
Funding Source: University Cancer Foundation - UTMDACC
Role: Principal Investigator
Duration: 11/4/2008 - 6/2011
 
Title: A clinical (therapeutic) trial of Revlimid (thalidomide analog) in refractory cancer pain and associated symptoms in patients with advanced cancer
Funding Source: Celgene Pharmaceuticals
Role: Principal Investigator
Duration: 5/22/2008 - 10/26/2011
 
Title: The Effect of Dexamethasone on Symptoms in Patients with Advanced Cancer
Funding Source: American Cancer Society (ACS)
Role: Principal Investigator
Duration: 1/2007 - 6/2011
 
Title: The effects of thalidomide on the cachexia symptom cluster and cytokines
Funding Source: Celgene Pharmaceuticals
Role: Co-Investigator
Principal Investigator: Bruera, MD
Duration: 8/2006 - 12/2009
 
Title: Feasibility, adherence and satisfaction of exercise + dexamethasone for cancer related fatigue in advanced cancer
Funding Source: Duncan Family Institute Research Projects Seed Funding Research Program
Role: Principal Investigator
 
Title: Feasibility, adherence and satisfaction of exercise + dexamethasone for cancer related fatigue in advanced cancer
Funding Source: UT MD Anderson - Institutional Research Grant (IRG)
Role: Principal Investigator

Last updated: 8/6/2013